Statistics
Publications
5
Citations
819
H-Index
5
Active since
2021
Thomas Davis is an author at Broad Institute specializing in cancer immunotherapy, molecular oncology, and tumor immunology.
Publications per year
2021–2024
5
5
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Gabriel K. Griffin, Jingyi Wu, Arvin Iracheta‐Vellve et al. · Nature · 2021 · 362 citations · Full text
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 174 citations · Full text
Targeting TBK1 to overcome resistance to cancer immunotherapy
Yi Sun, Or‐Yam Revach, Seth Anderson et al. · Nature · 2023 · 167 citations · Full text
Medicine, Cancer Biology, Oncology +12
1–5 of 5